# Filing Detail

Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-20-029638
Filing Date
2020-10-01
Accepted
2020-10-01 17:27:50
Documents
12

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PROSPECTUS | ea127698-424b4_aptorumgroup.htm | 424B4 | 1440994
2 | GRAPHIC | image_002.jpg | GRAPHIC | 78067
3 | GRAPHIC | image_003.jpg | GRAPHIC | 185070
4 | GRAPHIC | image_004.jpg | GRAPHIC | 22666
5 | GRAPHIC | image_005.jpg | GRAPHIC | 12499
6 | GRAPHIC | image_006.jpg | GRAPHIC | 36563
7 | GRAPHIC | image_007.jpg | GRAPHIC | 16856
8 | GRAPHIC | image_008.jpg | GRAPHIC | 66227
9 | GRAPHIC | image_009.jpg | GRAPHIC | 8224
10 | GRAPHIC | image_010.jpg | GRAPHIC | 175660
11 | GRAPHIC | image_011.jpg | GRAPHIC | 656392
12 | GRAPHIC | image_012.jpg | GRAPHIC | 78067
| Complete submission text file | 0001213900-20-029638.txt |  | 3266895

Mailing Address 17 HANOVER SQUARE LONDON X0 W1S 1BN
Business Address 17 HANOVER SQUARE LONDON X0 W1S 1BN 852 3953 7700
Aptorum Group Ltd (Filer) CIK: 0001734005 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-248743 | Film No.: 201217226
SIC: 2834 Pharmaceutical Preparations